Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tumber

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Nature Chemistry|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ<sup>2,4</sup>-amino acids targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, C David Owen, et al.
Chemmedchem|February 8, 2014
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1Rachel Schiller, Giuseppe Scozzafava, Anthony Tumber, et al.
The Journal of Biological Chemistry|May 10, 2022
Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteinsThomas M Leissing, Adam P Hardy, Hokfung Chan, et al.
The Biochemical Journal|September 18, 2007
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitorsNagma Khan, Michael Jeffers, Sampath Kumar, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Journal of Medicinal Chemistry|November 11, 2021
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) InhibitorsShifali Shishodia, Marina Demetriades, Dong Zhang, et al.
Journal of Medicinal Chemistry|December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activitiesDante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Journal of Medicinal Chemistry|March 23, 2013
Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligandsDavid S Hewings, Oleg Fedorov, Panagis Filippakopoulos, et al.
Nature Communications|September 15, 2016
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Laurence M Gagné, Marie-Eve Lalonde, et al.
Nature Communications|April 7, 2017
Highly selective inhibition of histone demethylases by de novo macrocyclic peptidesAkane Kawamura, Martin Münzel, Tatsuya Kojima, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Nature Chemistry|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ<sup>2,4</sup>-amino acids targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, C David Owen, et al.
Chemmedchem|February 8, 2014
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1Rachel Schiller, Giuseppe Scozzafava, Anthony Tumber, et al.
The Journal of Biological Chemistry|May 10, 2022
Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteinsThomas M Leissing, Adam P Hardy, Hokfung Chan, et al.
The Biochemical Journal|September 18, 2007
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitorsNagma Khan, Michael Jeffers, Sampath Kumar, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Journal of Medicinal Chemistry|November 11, 2021
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) InhibitorsShifali Shishodia, Marina Demetriades, Dong Zhang, et al.
Journal of Medicinal Chemistry|December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activitiesDante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Journal of Medicinal Chemistry|March 23, 2013
Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligandsDavid S Hewings, Oleg Fedorov, Panagis Filippakopoulos, et al.
Nature Communications|September 15, 2016
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Laurence M Gagné, Marie-Eve Lalonde, et al.
Nature Communications|April 7, 2017
Highly selective inhibition of histone demethylases by de novo macrocyclic peptidesAkane Kawamura, Martin Münzel, Tatsuya Kojima, et al.
Pageof 11